CA2100681A1 - Monoclonal antibodies to elam-1 and their uses - Google Patents
Monoclonal antibodies to elam-1 and their usesInfo
- Publication number
- CA2100681A1 CA2100681A1 CA002100681A CA2100681A CA2100681A1 CA 2100681 A1 CA2100681 A1 CA 2100681A1 CA 002100681 A CA002100681 A CA 002100681A CA 2100681 A CA2100681 A CA 2100681A CA 2100681 A1 CA2100681 A1 CA 2100681A1
- Authority
- CA
- Canada
- Prior art keywords
- elam
- immunoglobulin
- cells
- antibodies
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
- C07K16/2854—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72 against selectins, e.g. CD62
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6849—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Cell Biology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64587891A | 1991-01-24 | 1991-01-24 | |
US645,878 | 1991-01-24 | ||
US73303391A | 1991-07-22 | 1991-07-22 | |
US733,033 | 1991-07-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2100681A1 true CA2100681A1 (en) | 1992-07-25 |
Family
ID=27094802
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002100681A Abandoned CA2100681A1 (en) | 1991-01-24 | 1992-01-23 | Monoclonal antibodies to elam-1 and their uses |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0568631A4 (sk) |
JP (1) | JPH06505253A (sk) |
AU (1) | AU1269092A (sk) |
CA (1) | CA2100681A1 (sk) |
IE (1) | IE920206A1 (sk) |
IL (1) | IL100764A0 (sk) |
NO (1) | NO932672L (sk) |
NZ (1) | NZ241399A (sk) |
OA (1) | OA09809A (sk) |
SK (1) | SK77393A3 (sk) |
WO (1) | WO1992012729A1 (sk) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5646123A (en) * | 1991-06-10 | 1997-07-08 | Alberta Research Council | Time dependent administration of oligosaccharide glycosides related to blood group determinants having a type I or type II core structure in reducing inflammation in a sensitized mammal arising form exposure to an antigen |
US5877289A (en) * | 1992-03-05 | 1999-03-02 | The Scripps Research Institute | Tissue factor compositions and ligands for the specific coagulation of vasculature |
US5660827A (en) * | 1992-03-05 | 1997-08-26 | Board Of Regents, The University Of Texas System | Antibodies that bind to endoglin |
US6749853B1 (en) | 1992-03-05 | 2004-06-15 | Board Of Regents, The University Of Texas System | Combined methods and compositions for coagulation and tumor treatment |
US6004555A (en) * | 1992-03-05 | 1999-12-21 | Board Of Regents, The University Of Texas System | Methods for the specific coagulation of vasculature |
US6036955A (en) * | 1992-03-05 | 2000-03-14 | The Scripps Research Institute | Kits and methods for the specific coagulation of vasculature |
US5965132A (en) | 1992-03-05 | 1999-10-12 | Board Of Regents, The University Of Texas System | Methods and compositions for targeting the vasculature of solid tumors |
US6093399A (en) * | 1992-03-05 | 2000-07-25 | Board Of Regents, The University Of Texas System | Methods and compositions for the specific coagulation of vasculature |
ATE239506T1 (de) * | 1992-03-05 | 2003-05-15 | Univ Texas | Verwendung von immunokonjugate zur diagnose und/oder therapie der vaskularisierten tumoren |
US5643873A (en) * | 1992-05-06 | 1997-07-01 | Affymax Technologies N.V. | Peptides and compounds that bind selectins including endothelial leukocyte adhesion molecule 1 |
US5648458A (en) * | 1992-05-06 | 1997-07-15 | Affymax Technologies N.V. | Peptides and compounds that bind to ELAM-1 |
US5728802A (en) * | 1992-05-06 | 1998-03-17 | Affymax Technologies N.V. | Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (ELAM-1) |
EP0602290B1 (en) * | 1992-12-04 | 1999-08-25 | ConjuChem, Inc. | Antibody-conjugated Hepatitis B surface antigen and use thereof |
US5723116A (en) * | 1995-01-06 | 1998-03-03 | University Of South Florida | Decreased mortality of severe acute pancreatitis following proximal cytokine blockade |
WO1996040942A1 (en) * | 1995-06-07 | 1996-12-19 | Cytel Corporation | Humanized antibodies to e-selectin |
US6537520B1 (en) | 1998-03-31 | 2003-03-25 | Bristol-Myers Squibb Pharma Company | Pharmaceuticals for the imaging of angiogenic disorders |
US6524553B2 (en) | 1998-03-31 | 2003-02-25 | Bristol-Myers Squibb Pharma Company | Quinolone vitronectin receptor antagonist pharmaceuticals |
US6548663B1 (en) | 1998-03-31 | 2003-04-15 | Bristol-Myers Squibb Pharma Company | Benzodiazepine vitronectin receptor antagonist pharmaceuticals |
US6818213B1 (en) | 1998-07-13 | 2004-11-16 | Board Of Regents, The University Of Texas System | Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids |
US7067109B1 (en) | 1998-07-13 | 2006-06-27 | Board Of Regents, The University Of Texas System | Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids |
US6794518B1 (en) | 1998-12-18 | 2004-09-21 | Bristol-Myers Squibb Pharma Company | Vitronectin receptor antagonist pharmaceuticals |
TR200101757T2 (tr) | 1998-12-18 | 2001-12-21 | Dupont Pharmaceuticais Company | Vitronektin reseptör antagonisti farmasötikler |
US6511649B1 (en) | 1998-12-18 | 2003-01-28 | Thomas D. Harris | Vitronectin receptor antagonist pharmaceuticals |
US6569402B1 (en) | 1998-12-18 | 2003-05-27 | Bristol-Myers Squibb Pharma Company | Vitronectin receptor antagonist pharmaceuticals |
CN1356913A (zh) | 1998-12-18 | 2002-07-03 | 杜邦药品公司 | 玻连蛋白受体拮抗剂药物 |
US7030219B2 (en) | 2000-04-28 | 2006-04-18 | Johns Hopkins University | B7-DC, Dendritic cell co-stimulatory molecules |
KR20110074850A (ko) * | 2008-08-25 | 2011-07-04 | 앰플리뮨, 인크. | Pd-1 길항제 및 그의 사용 방법 |
JP7185884B2 (ja) | 2017-05-02 | 2022-12-08 | 国立研究開発法人国立精神・神経医療研究センター | Il-6及び好中球の関連する疾患の治療効果の予測及び判定方法 |
WO2019078344A1 (ja) * | 2017-10-20 | 2019-04-25 | 学校法人兵庫医科大学 | 抗il-6受容体抗体を含有する術後の癒着を抑制するための医薬組成物 |
WO2021148983A1 (en) | 2020-01-24 | 2021-07-29 | Pfizer Inc. | Anti-e-selectin antibodies, compositions and methods of use |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04501565A (ja) * | 1988-11-14 | 1992-03-19 | ブリガム・アンド・ウイメンズ・ホスピタル | Elam―1に特異的な抗体およびその用途 |
US5081034A (en) * | 1988-11-14 | 1992-01-14 | Brigham & Women's Hospital | Cloned genes which encode elam-1 |
US5272263A (en) * | 1989-04-28 | 1993-12-21 | Biogen, Inc. | DNA sequences encoding vascular cell adhesion molecules (VCAMS) |
-
1992
- 1992-01-23 AU AU12690/92A patent/AU1269092A/en not_active Abandoned
- 1992-01-23 SK SK773-93A patent/SK77393A3/sk unknown
- 1992-01-23 IE IE020692A patent/IE920206A1/en not_active Application Discontinuation
- 1992-01-23 CA CA002100681A patent/CA2100681A1/en not_active Abandoned
- 1992-01-23 WO PCT/US1992/000577 patent/WO1992012729A1/en not_active Application Discontinuation
- 1992-01-23 EP EP92905123A patent/EP0568631A4/en not_active Withdrawn
- 1992-01-23 JP JP4505427A patent/JPH06505253A/ja active Pending
- 1992-01-24 IL IL100764A patent/IL100764A0/xx unknown
- 1992-01-24 NZ NZ241399A patent/NZ241399A/en unknown
-
1993
- 1993-07-22 OA OA60394A patent/OA09809A/en unknown
- 1993-07-23 NO NO93932672A patent/NO932672L/no unknown
Also Published As
Publication number | Publication date |
---|---|
AU1269092A (en) | 1992-08-27 |
NZ241399A (en) | 1994-06-27 |
OA09809A (en) | 1994-04-15 |
WO1992012729A1 (en) | 1992-08-06 |
IL100764A0 (en) | 1992-09-06 |
IE920206A1 (en) | 1992-07-29 |
NO932672D0 (no) | 1993-07-23 |
EP0568631A1 (en) | 1993-11-10 |
JPH06505253A (ja) | 1994-06-16 |
EP0568631A4 (en) | 1995-04-05 |
NO932672L (no) | 1993-09-23 |
SK77393A3 (en) | 1994-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2100681A1 (en) | Monoclonal antibodies to elam-1 and their uses | |
Myones et al. | Neutrophil and monocyte cell surface p150, 95 has iC3b-receptor (CR4) activity resembling CR3. | |
CA2210620C (en) | Anti-cd 30 antibodies preventing proteolytic cleavage and release of membrane-bound cd 30 antigen | |
JP3691467B2 (ja) | セレクチンリガンド | |
EP0712307B1 (en) | Methods for b-cell population control | |
AU674302B2 (en) | Treatment for inflammatory bowel disease | |
US7071310B1 (en) | Antibody against the human toll- like receptor 2 (tlr2) and uses thereof | |
CA2134966C (en) | Antibodies with specificity for multiple adhesion molecules | |
US5932217A (en) | Peptides which inhibit adhesion between leukocytes and endothelial cells | |
US5580780A (en) | Vascular adhesion protein-(VAP-1) and VAP-1-specific antibodies | |
US5792457A (en) | Antibody recognizing endothelial cell ligand for leukocyte CR3 | |
CA2095404A1 (en) | Purification and characterization of a csvtcg-specific tumor cell adhesion receptor | |
EP0434685A1 (en) | Gram-negative bacterial endotoxin blocking monoclonal antibodies | |
CA2182215A1 (en) | Anti-inflammatory containing monoclonal antibodies having reactivity with sialyl-lewis x sugar chains originating in hemangioendothelial cell membrane | |
AU6122894A (en) | Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof | |
EP0584273B1 (en) | Antibody recognizing endothelial cell ligand for leukocyte cr3 | |
WO1993002698A1 (en) | Monoclonal antibodies to leukocyte adhesion molecule-1 | |
EP0726942A1 (en) | Human foam cells and methods for preparing them, monoclonal antibodies to said foam cells and their pharmaceutical and diagnostic use | |
JPH06508991A (ja) | リンパ細胞に結合した表面タンパク質に対するモノクローナル抗体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |